Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. - Hammes,H.P.; Du,X.; Edelstein,D.; Taguchi,T.; Matsumura,T.; Ju,Q.; Lin,J.; Bierhaus,A.; Nawroth,P.; Hannak,D.; Neumaier,M.; Bergfeld,R.; et al. (Nat Med, 2003)